Molecular identification of nicotinic acid receptor.

Nicotinic acid and its derivative, Acipimox, have been widely used in the treatment of hyperlipidemia. Pharmacological studies have demonstrated that they exert the beneficial effect through the activation of a Gi-protein-coupled receptor on adipocyte, which has remained elusive to date. Here we show that a novel GPCR, designated HM74b because of its high similarity to HM74, is a receptor for nicotinic acid. HM74b mRNA is found in human, murine, and rat adipose tissues. Nicotinic acid and Acipimox inhibit forskolin-stimulated intracellular cAMP accumulation in human HM74b-expressing cells and activate GTP gamma S binding in a dose-dependent manner. [3H]Nicotinic acid specifically binds to HM74b-expressing membrane and its binding is replaced by Acipimox. This finding will open a new phase of research on the physiological role of nicotinic acid and will be a clue to develop novel antihyperlipidemic drugs.

Citation

Takatoshi Soga, Masazumi Kamohara, Jun Takasaki, Shun-ichiro Matsumoto, Tetsu Saito, Takahide Ohishi, Hideki Hiyama, Ayako Matsuo, Hitoshi Matsushime, Kiyoshi Furuichi. Molecular identification of nicotinic acid receptor. Biochemical and biophysical research communications. 2003 Mar 28;303(1):364-9

Mesh Tags

Substances

PMID: 12646212

search → result